EBOS dismisses acquisition rumours

Pet food company not on EBOS's takeover menu as ASX-listed firm eyes expansion Pharmaceutical wholesaler, Symbion’s parent company has told the Australian Securities Exchange (ASX) that it “will not be participating in any potential forthcoming sale of Prime100”.  The company issued the statement distancing itself from the Australian-owned pet food firm earlier this week after